Global Equine Drugs and Supplement Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Equine Drugs and Supplement market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Equine Drugs and Supplement market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Equine Drugs and Supplement market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Drugs and Supplement market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Drugs and Supplement market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Drugs and Supplement market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Equine Drugs and Supplement
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Equine Drugs and Supplement market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health and Merial, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Equine Drugs and Supplement market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Equine Drugs and Supplement product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Drugs and Supplement, with price, sales, revenue and global market share of Equine Drugs and Supplement from 2018 to 2023.
Chapter 3, the Equine Drugs and Supplement competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Drugs and Supplement breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Equine Drugs and Supplement market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Drugs and Supplement.
Chapter 14 and 15, to describe Equine Drugs and Supplement sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Equine Drugs and Supplement market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Equine Drugs and Supplement market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Drugs and Supplement market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Drugs and Supplement market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Drugs and Supplement market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Equine Drugs and Supplement
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Equine Drugs and Supplement market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health and Merial, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Equine Drugs and Supplement market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Supplements
- Pharmaceutical Drugs
- Drugstores
- Veterinary Hospitals
- Others
- Bayer Animal Health
- Boehringer Ingelheim
- Elanco (Eli Lilly)
- Merck Animal Health
- Merial
- Novartis Animal Health
- Zoetis
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Equine Drugs and Supplement product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Drugs and Supplement, with price, sales, revenue and global market share of Equine Drugs and Supplement from 2018 to 2023.
Chapter 3, the Equine Drugs and Supplement competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Drugs and Supplement breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Equine Drugs and Supplement market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Drugs and Supplement.
Chapter 14 and 15, to describe Equine Drugs and Supplement sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Equine Drugs and Supplement
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Equine Drugs and Supplement Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Supplements
1.3.3 Pharmaceutical Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Equine Drugs and Supplement Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Drugstores
1.4.3 Veterinary Hospitals
1.4.4 Others
1.5 Global Equine Drugs and Supplement Market Size & Forecast
1.5.1 Global Equine Drugs and Supplement Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Equine Drugs and Supplement Sales Quantity (2018-2029)
1.5.3 Global Equine Drugs and Supplement Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Bayer Animal Health
2.1.1 Bayer Animal Health Details
2.1.2 Bayer Animal Health Major Business
2.1.3 Bayer Animal Health Equine Drugs and Supplement Product and Services
2.1.4 Bayer Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Animal Health Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Equine Drugs and Supplement Product and Services
2.2.4 Boehringer Ingelheim Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 Elanco (Eli Lilly)
2.3.1 Elanco (Eli Lilly) Details
2.3.2 Elanco (Eli Lilly) Major Business
2.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Product and Services
2.3.4 Elanco (Eli Lilly) Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Elanco (Eli Lilly) Recent Developments/Updates
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business
2.4.3 Merck Animal Health Equine Drugs and Supplement Product and Services
2.4.4 Merck Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Animal Health Recent Developments/Updates
2.5 Merial
2.5.1 Merial Details
2.5.2 Merial Major Business
2.5.3 Merial Equine Drugs and Supplement Product and Services
2.5.4 Merial Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merial Recent Developments/Updates
2.6 Novartis Animal Health
2.6.1 Novartis Animal Health Details
2.6.2 Novartis Animal Health Major Business
2.6.3 Novartis Animal Health Equine Drugs and Supplement Product and Services
2.6.4 Novartis Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Animal Health Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Equine Drugs and Supplement Product and Services
2.7.4 Zoetis Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zoetis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EQUINE DRUGS AND SUPPLEMENT BY MANUFACTURER
3.1 Global Equine Drugs and Supplement Sales Quantity by Manufacturer (2018-2023)
3.2 Global Equine Drugs and Supplement Revenue by Manufacturer (2018-2023)
3.3 Global Equine Drugs and Supplement Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Equine Drugs and Supplement by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Equine Drugs and Supplement Manufacturer Market Share in 2022
3.4.2 Top 6 Equine Drugs and Supplement Manufacturer Market Share in 2022
3.5 Equine Drugs and Supplement Market: Overall Company Footprint Analysis
3.5.1 Equine Drugs and Supplement Market: Region Footprint
3.5.2 Equine Drugs and Supplement Market: Company Product Type Footprint
3.5.3 Equine Drugs and Supplement Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Equine Drugs and Supplement Market Size by Region
4.1.1 Global Equine Drugs and Supplement Sales Quantity by Region (2018-2029)
4.1.2 Global Equine Drugs and Supplement Consumption Value by Region (2018-2029)
4.1.3 Global Equine Drugs and Supplement Average Price by Region (2018-2029)
4.2 North America Equine Drugs and Supplement Consumption Value (2018-2029)
4.3 Europe Equine Drugs and Supplement Consumption Value (2018-2029)
4.4 Asia-Pacific Equine Drugs and Supplement Consumption Value (2018-2029)
4.5 South America Equine Drugs and Supplement Consumption Value (2018-2029)
4.6 Middle East and Africa Equine Drugs and Supplement Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
5.2 Global Equine Drugs and Supplement Consumption Value by Type (2018-2029)
5.3 Global Equine Drugs and Supplement Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
6.2 Global Equine Drugs and Supplement Consumption Value by Application (2018-2029)
6.3 Global Equine Drugs and Supplement Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
7.2 North America Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
7.3 North America Equine Drugs and Supplement Market Size by Country
7.3.1 North America Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
7.3.2 North America Equine Drugs and Supplement Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
8.2 Europe Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
8.3 Europe Equine Drugs and Supplement Market Size by Country
8.3.1 Europe Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
8.3.2 Europe Equine Drugs and Supplement Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Equine Drugs and Supplement Market Size by Region
9.3.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
10.2 South America Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
10.3 South America Equine Drugs and Supplement Market Size by Country
10.3.1 South America Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
10.3.2 South America Equine Drugs and Supplement Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Equine Drugs and Supplement Market Size by Country
11.3.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Equine Drugs and Supplement Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Equine Drugs and Supplement Market Drivers
12.2 Equine Drugs and Supplement Market Restraints
12.3 Equine Drugs and Supplement Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Equine Drugs and Supplement and Key Manufacturers
13.2 Manufacturing Costs Percentage of Equine Drugs and Supplement
13.3 Equine Drugs and Supplement Production Process
13.4 Equine Drugs and Supplement Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Equine Drugs and Supplement Typical Distributors
14.3 Equine Drugs and Supplement Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Equine Drugs and Supplement
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Equine Drugs and Supplement Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Supplements
1.3.3 Pharmaceutical Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Equine Drugs and Supplement Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Drugstores
1.4.3 Veterinary Hospitals
1.4.4 Others
1.5 Global Equine Drugs and Supplement Market Size & Forecast
1.5.1 Global Equine Drugs and Supplement Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Equine Drugs and Supplement Sales Quantity (2018-2029)
1.5.3 Global Equine Drugs and Supplement Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Bayer Animal Health
2.1.1 Bayer Animal Health Details
2.1.2 Bayer Animal Health Major Business
2.1.3 Bayer Animal Health Equine Drugs and Supplement Product and Services
2.1.4 Bayer Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Animal Health Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Equine Drugs and Supplement Product and Services
2.2.4 Boehringer Ingelheim Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 Elanco (Eli Lilly)
2.3.1 Elanco (Eli Lilly) Details
2.3.2 Elanco (Eli Lilly) Major Business
2.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Product and Services
2.3.4 Elanco (Eli Lilly) Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Elanco (Eli Lilly) Recent Developments/Updates
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business
2.4.3 Merck Animal Health Equine Drugs and Supplement Product and Services
2.4.4 Merck Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Animal Health Recent Developments/Updates
2.5 Merial
2.5.1 Merial Details
2.5.2 Merial Major Business
2.5.3 Merial Equine Drugs and Supplement Product and Services
2.5.4 Merial Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merial Recent Developments/Updates
2.6 Novartis Animal Health
2.6.1 Novartis Animal Health Details
2.6.2 Novartis Animal Health Major Business
2.6.3 Novartis Animal Health Equine Drugs and Supplement Product and Services
2.6.4 Novartis Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Animal Health Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Equine Drugs and Supplement Product and Services
2.7.4 Zoetis Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zoetis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EQUINE DRUGS AND SUPPLEMENT BY MANUFACTURER
3.1 Global Equine Drugs and Supplement Sales Quantity by Manufacturer (2018-2023)
3.2 Global Equine Drugs and Supplement Revenue by Manufacturer (2018-2023)
3.3 Global Equine Drugs and Supplement Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Equine Drugs and Supplement by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Equine Drugs and Supplement Manufacturer Market Share in 2022
3.4.2 Top 6 Equine Drugs and Supplement Manufacturer Market Share in 2022
3.5 Equine Drugs and Supplement Market: Overall Company Footprint Analysis
3.5.1 Equine Drugs and Supplement Market: Region Footprint
3.5.2 Equine Drugs and Supplement Market: Company Product Type Footprint
3.5.3 Equine Drugs and Supplement Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Equine Drugs and Supplement Market Size by Region
4.1.1 Global Equine Drugs and Supplement Sales Quantity by Region (2018-2029)
4.1.2 Global Equine Drugs and Supplement Consumption Value by Region (2018-2029)
4.1.3 Global Equine Drugs and Supplement Average Price by Region (2018-2029)
4.2 North America Equine Drugs and Supplement Consumption Value (2018-2029)
4.3 Europe Equine Drugs and Supplement Consumption Value (2018-2029)
4.4 Asia-Pacific Equine Drugs and Supplement Consumption Value (2018-2029)
4.5 South America Equine Drugs and Supplement Consumption Value (2018-2029)
4.6 Middle East and Africa Equine Drugs and Supplement Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
5.2 Global Equine Drugs and Supplement Consumption Value by Type (2018-2029)
5.3 Global Equine Drugs and Supplement Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
6.2 Global Equine Drugs and Supplement Consumption Value by Application (2018-2029)
6.3 Global Equine Drugs and Supplement Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
7.2 North America Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
7.3 North America Equine Drugs and Supplement Market Size by Country
7.3.1 North America Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
7.3.2 North America Equine Drugs and Supplement Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
8.2 Europe Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
8.3 Europe Equine Drugs and Supplement Market Size by Country
8.3.1 Europe Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
8.3.2 Europe Equine Drugs and Supplement Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Equine Drugs and Supplement Market Size by Region
9.3.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
10.2 South America Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
10.3 South America Equine Drugs and Supplement Market Size by Country
10.3.1 South America Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
10.3.2 South America Equine Drugs and Supplement Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Equine Drugs and Supplement Market Size by Country
11.3.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Equine Drugs and Supplement Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Equine Drugs and Supplement Market Drivers
12.2 Equine Drugs and Supplement Market Restraints
12.3 Equine Drugs and Supplement Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Equine Drugs and Supplement and Key Manufacturers
13.2 Manufacturing Costs Percentage of Equine Drugs and Supplement
13.3 Equine Drugs and Supplement Production Process
13.4 Equine Drugs and Supplement Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Equine Drugs and Supplement Typical Distributors
14.3 Equine Drugs and Supplement Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Equine Drugs and Supplement Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Equine Drugs and Supplement Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Animal Health Major Business
Table 5. Bayer Animal Health Equine Drugs and Supplement Product and Services
Table 6. Bayer Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Animal Health Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Equine Drugs and Supplement Product and Services
Table 11. Boehringer Ingelheim Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. Elanco (Eli Lilly) Basic Information, Manufacturing Base and Competitors
Table 14. Elanco (Eli Lilly) Major Business
Table 15. Elanco (Eli Lilly) Equine Drugs and Supplement Product and Services
Table 16. Elanco (Eli Lilly) Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Elanco (Eli Lilly) Recent Developments/Updates
Table 18. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 19. Merck Animal Health Major Business
Table 20. Merck Animal Health Equine Drugs and Supplement Product and Services
Table 21. Merck Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Animal Health Recent Developments/Updates
Table 23. Merial Basic Information, Manufacturing Base and Competitors
Table 24. Merial Major Business
Table 25. Merial Equine Drugs and Supplement Product and Services
Table 26. Merial Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Merial Recent Developments/Updates
Table 28. Novartis Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Animal Health Major Business
Table 30. Novartis Animal Health Equine Drugs and Supplement Product and Services
Table 31. Novartis Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Animal Health Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Equine Drugs and Supplement Product and Services
Table 36. Zoetis Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zoetis Recent Developments/Updates
Table 38. Global Equine Drugs and Supplement Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Equine Drugs and Supplement Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Equine Drugs and Supplement Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Equine Drugs and Supplement, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Equine Drugs and Supplement Production Site of Key Manufacturer
Table 43. Equine Drugs and Supplement Market: Company Product Type Footprint
Table 44. Equine Drugs and Supplement Market: Company Product Application Footprint
Table 45. Equine Drugs and Supplement New Market Entrants and Barriers to Market Entry
Table 46. Equine Drugs and Supplement Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Equine Drugs and Supplement Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Equine Drugs and Supplement Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Equine Drugs and Supplement Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Equine Drugs and Supplement Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Equine Drugs and Supplement Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Equine Drugs and Supplement Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Equine Drugs and Supplement Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Equine Drugs and Supplement Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Equine Drugs and Supplement Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Equine Drugs and Supplement Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Equine Drugs and Supplement Raw Material
Table 106. Key Manufacturers of Equine Drugs and Supplement Raw Materials
Table 107. Equine Drugs and Supplement Typical Distributors
Table 108. Equine Drugs and Supplement Typical Customers
Table 1. Global Equine Drugs and Supplement Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Equine Drugs and Supplement Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Animal Health Major Business
Table 5. Bayer Animal Health Equine Drugs and Supplement Product and Services
Table 6. Bayer Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Animal Health Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Equine Drugs and Supplement Product and Services
Table 11. Boehringer Ingelheim Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. Elanco (Eli Lilly) Basic Information, Manufacturing Base and Competitors
Table 14. Elanco (Eli Lilly) Major Business
Table 15. Elanco (Eli Lilly) Equine Drugs and Supplement Product and Services
Table 16. Elanco (Eli Lilly) Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Elanco (Eli Lilly) Recent Developments/Updates
Table 18. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 19. Merck Animal Health Major Business
Table 20. Merck Animal Health Equine Drugs and Supplement Product and Services
Table 21. Merck Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Animal Health Recent Developments/Updates
Table 23. Merial Basic Information, Manufacturing Base and Competitors
Table 24. Merial Major Business
Table 25. Merial Equine Drugs and Supplement Product and Services
Table 26. Merial Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Merial Recent Developments/Updates
Table 28. Novartis Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Animal Health Major Business
Table 30. Novartis Animal Health Equine Drugs and Supplement Product and Services
Table 31. Novartis Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Animal Health Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Equine Drugs and Supplement Product and Services
Table 36. Zoetis Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zoetis Recent Developments/Updates
Table 38. Global Equine Drugs and Supplement Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Equine Drugs and Supplement Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Equine Drugs and Supplement Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Equine Drugs and Supplement, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Equine Drugs and Supplement Production Site of Key Manufacturer
Table 43. Equine Drugs and Supplement Market: Company Product Type Footprint
Table 44. Equine Drugs and Supplement Market: Company Product Application Footprint
Table 45. Equine Drugs and Supplement New Market Entrants and Barriers to Market Entry
Table 46. Equine Drugs and Supplement Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Equine Drugs and Supplement Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Equine Drugs and Supplement Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Equine Drugs and Supplement Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Equine Drugs and Supplement Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Equine Drugs and Supplement Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Equine Drugs and Supplement Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Equine Drugs and Supplement Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Equine Drugs and Supplement Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Equine Drugs and Supplement Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Equine Drugs and Supplement Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Equine Drugs and Supplement Raw Material
Table 106. Key Manufacturers of Equine Drugs and Supplement Raw Materials
Table 107. Equine Drugs and Supplement Typical Distributors
Table 108. Equine Drugs and Supplement Typical Customers
LIST OF FIGURES
Figure 1. Equine Drugs and Supplement Picture
Figure 2. Global Equine Drugs and Supplement Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Equine Drugs and Supplement Consumption Value Market Share by Type in 2022
Figure 4. Supplements Examples
Figure 5. Pharmaceutical Drugs Examples
Figure 6. Global Equine Drugs and Supplement Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Equine Drugs and Supplement Consumption Value Market Share by Application in 2022
Figure 8. Drugstores Examples
Figure 9. Veterinary Hospitals Examples
Figure 10. Others Examples
Figure 11. Global Equine Drugs and Supplement Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Equine Drugs and Supplement Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Equine Drugs and Supplement Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Equine Drugs and Supplement Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Equine Drugs and Supplement Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Equine Drugs and Supplement Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Equine Drugs and Supplement by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Equine Drugs and Supplement Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Equine Drugs and Supplement Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Equine Drugs and Supplement Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Equine Drugs and Supplement Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Equine Drugs and Supplement Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Equine Drugs and Supplement Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 53. China Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Equine Drugs and Supplement Market Drivers
Figure 74. Equine Drugs and Supplement Market Restraints
Figure 75. Equine Drugs and Supplement Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Equine Drugs and Supplement in 2022
Figure 78. Manufacturing Process Analysis of Equine Drugs and Supplement
Figure 79. Equine Drugs and Supplement Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Equine Drugs and Supplement Picture
Figure 2. Global Equine Drugs and Supplement Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Equine Drugs and Supplement Consumption Value Market Share by Type in 2022
Figure 4. Supplements Examples
Figure 5. Pharmaceutical Drugs Examples
Figure 6. Global Equine Drugs and Supplement Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Equine Drugs and Supplement Consumption Value Market Share by Application in 2022
Figure 8. Drugstores Examples
Figure 9. Veterinary Hospitals Examples
Figure 10. Others Examples
Figure 11. Global Equine Drugs and Supplement Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Equine Drugs and Supplement Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Equine Drugs and Supplement Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Equine Drugs and Supplement Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Equine Drugs and Supplement Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Equine Drugs and Supplement Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Equine Drugs and Supplement by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Equine Drugs and Supplement Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Equine Drugs and Supplement Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Equine Drugs and Supplement Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Equine Drugs and Supplement Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Equine Drugs and Supplement Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Equine Drugs and Supplement Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 53. China Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Equine Drugs and Supplement Market Drivers
Figure 74. Equine Drugs and Supplement Market Restraints
Figure 75. Equine Drugs and Supplement Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Equine Drugs and Supplement in 2022
Figure 78. Manufacturing Process Analysis of Equine Drugs and Supplement
Figure 79. Equine Drugs and Supplement Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
